Chimeric Therapeutics LimitedASX: CHM

CDH17 granted FDA Orphan Drug Designation for Gastric Cancer

Dec 8, 2025 at 2:53 AM UTC · Issued by Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release.

View Attachment